Endocyte, Inc. (ECYT) Tops Q4 Loss Views by 4c

Endocyte, Inc. (NASDAQ: ECYT) reported Q4 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Endocyte, Inc. (ECYT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c